444 related articles for article (PubMed ID: 27805252)
21. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
22. HIF-1α Promotes Breast Cancer Cell MCF-7 Proliferation and Invasion Through Regulating miR-210.
Zhang Y; Yan J; Wang L; Dai H; Li N; Hu W; Cai H
Cancer Biother Radiopharm; 2017 Oct; 32(8):297-301. PubMed ID: 29053417
[TBL] [Abstract][Full Text] [Related]
23. HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.
Fanale D; Bazan V; Corsini LR; Caruso S; Insalaco L; Castiglia M; Cicero G; Bronte G; Russo A
Breast Cancer Res Treat; 2013 Aug; 140(3):505-17. PubMed ID: 23925655
[TBL] [Abstract][Full Text] [Related]
24. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
25. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
27. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer.
Chen HH; Su WC; Lin PW; Guo HR; Lee WY
Breast Cancer Res Treat; 2007 Jun; 103(2):167-75. PubMed ID: 17028975
[TBL] [Abstract][Full Text] [Related]
29. Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer.
Lin CS; Liu TC; Lee MT; Yang SF; Tsao TC
Int J Med Sci; 2017; 14(8):785-790. PubMed ID: 28824314
[TBL] [Abstract][Full Text] [Related]
30. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance].
Lin P; Wang W; Cai WJ; Han CR; Sun Y; Li M; Sun BC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):480-5. PubMed ID: 19954019
[TBL] [Abstract][Full Text] [Related]
32. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
33. Comparative expression analysis of hypoxia-inducible factor-alpha and its natural occurring antisense in breast cancer tissues and adjacent noncancerous tissues.
Tasharrofi B; Soudyab M; Nikpayam E; Iranpour M; Mirfakhraie R; Sarrafzadeh S; Geranpayeh L; Azargashb E; Sayad A; Ghafouri-Fard S
Cell Biochem Funct; 2016 Dec; 34(8):572-578. PubMed ID: 27862063
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
35. Association between the expression of HIF-1α and VEGF and prognostic implications in primary liver cancer.
Guo LY; Zhu P; Jin XP
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173353
[TBL] [Abstract][Full Text] [Related]
36. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
Abouhashem NS; Ibrahim DA; Mohamed AM
Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
[TBL] [Abstract][Full Text] [Related]
38. Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.
Zhang J; Cheng Q; Zhou Y; Wang Y; Chen X
Oral Oncol; 2013 Nov; 49(11):1043-50. PubMed ID: 24035721
[TBL] [Abstract][Full Text] [Related]
39. HIF-1α acts downstream of TNF-α to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells.
Su K; Tian Y; Wang J; Shi W; Luo D; Liu J; Tong Z; Wu J; Zhang J; Wei L
DNA Cell Biol; 2012 Jun; 31(6):1078-87. PubMed ID: 22320863
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]